Skip to main content

Table 1 Clinicopathological variables of BC patients

From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis

Characteristic

Status

Number of patients

Stage

I

8 (16%)

II

15 (30%)

III

12 (24%)

IV

9 (18%)

Unknown

6 (12%)

Age

 < 45

20 (40%)

 > 45

24 (48%)

Unknown

6 (12%)

Lymph node metastasis

Yes

17 (34%)

No

26 (52%)

Unknown

7 (14%)

Tumor size (TS)

 < 2 cm

15 (30%)

5 > TS > 2

5 (10%)

 > 5 cm

29 (58%)

Unknown

1 (2%)

Menopausal status

Yes

12 (24%)

No

15 (30%)

Unknown

23 (46%)

ER receptor

Positive

14 (28%)

Negative

13 (26%)

Unknown

23 (46%)

PR receptor

Positive

19 (38%)

Negative

21 (42%)

Unknown

10 (20%)

HER2/neu receptor

Positive

12 (24%)

Negative

21 (42%)

Unknown

17 (34%)